Nourish’s Series C round was led by Menlo Ventures, with participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak and Operator Partners. The post Nourish Secures $100M for Metabolic Health Clinic appeared first on MedCity News.
President Donald Trump’s administrations have been notorious for an array of “alternative facts” — ranging from the relatively minor (the size of inaugural crowds) to threats to U.S. democracy, such as who really won the 2020 election. And over the past six months, the stakes have been life or death: Trump’s health officials have been…
When applied with a rigorous, subject-matter-expert guided process, AI-currated RWD is an essential resource giving life science organizations new power to monitor the diverse variety of ways drugs are actually utilized post-approval. The post Blinded by Science: The Importance of RWD and Post-market Surveillance appeared first on MedCity News.
Growth without structural discipline creates risk. And the risk that has gone largely unexamined in the DPC advocacy space is the one that matters most to the broader healthcare system: what happens to insurance risk pools when healthy lives migrate out of them? The post DPC Is Scaling — The Financing Architecture Isn’t Ready appeared…
This summer, the state of Louisiana texted just over 13,000 people enrolled in its Medicaid program with a link to a website where they could confirm their incomes. The texts were part of a pilot run to test technology the Trump administration says will make it easier for some Medicaid enrollees to prove they meet…
Pharmacies and wholesalers claimed Takeda Pharmaceutical delayed generic competition from entering the market, forcing them to overpay for a gastrointestinal drug. Takeda said the trial had “evidentiary and legal errors,” and the company will appeal the verdict. The post Takeda Vows Appeal of $885M Jury Verdict in ‘Pay-for-Delay’ Antitrust Case appeared first on MedCity News.
Pathos AI struck a deal for rights to a bispecific antibody drug conjugate from Alphamab that could become first in a new class of cancer drugs. Separately, the startup began a partnership with AstraZeneca on a protein degrader from the pharma company’s cancer drug pipeline. The post Pathos Picks Up Two Cancer Drugs Poised for…
Devices can send information back to a physician, but that data doesn’t explain how the experience felt. Without that context, healthcare teams miss the very details that shape adherence, satisfaction, and long-term outcomes. The post Beyond Data Logs: Capturing The Real-World Experience Of Medical Devices At Home appeared first on MedCity News.
Bain & Co./KLAS Research survey finds 75% of providers and payers have increased IT investments
Elizabeth Bonker is a silent woman with a loud mission. She wants government agencies to cover the costs of training people with autism in a form of communication called assisted spelling. One problem: Leading professional organizations don’t believe it works. “All nonspeakers above the age of 5 should be given the opportunity,” typed Bonker, who…